Journal of Diabetes Research / 2019 / Article / Tab 3

Research Article

Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes

Table 3

The characters of the two patients who had a and without insulin or secretagogue treatment.

Patient 1Patent 2

SexMaleFemale
Diagnosis age (yrs)2960
Age (yrs)2973
Diabetes duration (yrs)0.613
BMI (kg/m2)21.919.5
SBP (mmHg)96135
DBP (mmHg)6070
WL (cm)6878
TG (mmol/L)2.930.61
TC (mmol/L)6.45.69
HDL-c (mmol/L)1.101.92
LDL-c (mmol/L)3.902.73
UA (μmol/L)292194
FBG (mmol/L)9.45.13
FCP (nmol/L)0.600.3
PCP (nmol/L)0.711.77
FINS (μU/ml)2.7231.18
PINS (μU/ml)5.928.20
UCPCR (nmol/mmol)0.110.11
A1C (%)13.56.6
Complications
 DN (%)
 DR (%)
 DPN (%)+
Treatment (%)
Metformin 500 mg t.i.d.Metformin 250 mg t.i.d.
Acarbose tablet 50 mg t.i.d.Acarbose tablet 50 mg t.i.d.

Data is median (interquartile range), unless otherwise stated. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; WL: waistline; TG: triglyceride; TC: total cholesterol; HDL-c: high-density lipoprotein-cholesterol; LDL-c: low-density lipoprotein-cholesterol; UA: uric acid; FBG: fasting blood glucose; FCP: fasting C-peptide; PCP: postprandial C-peptide; A1C: HbA1c; DN: diabetic nephropathy; DR: diabetic retinopathy; DPN: diabetic peripheral neuropath; OHA: oral hypoglycemic agent. Statistical significance.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.